Chen Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chen Zhang has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Yongan Sun
Department of Neurology, Peking University First Hospital, Peking University
4 shared publications - Jiong Shi
Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei China
2 shared publications Xuhui Chen
Peking University Shenzhen Hospital
2 shared publications- Ailian Du
Department of Neurology, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication Anqi Li
Institute of Neurological and Psychiatric Disorders, Shenzhen Bay Laboratory, Shenzhen 518132, China; Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong 999077, China
1 shared publication- Binhui Liu
Institute of Neurological and Psychiatric Disorders, Shenzhen Bay Laboratory, Shenzhen 518132, China
1 shared publication
Latest Publications
- Open Access
- 23 September 2026
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 18, 1937244
Blood biomarkers and artificial intelligence: toward precision medicine in Alzheimer’s disease
The integration of blood-based biomarkers and artificial intelligence (AI) is revolutionizing the diagnostic landscape of Alzheimer’s disease (AD). In this paper, we synthesize recent advancements in the application of machine learning (ML) on blood biomarker analysis, evaluating their diagnostic efficacy and clinical translational potential. Current evidence identifies plasma p-tau217 as the best individual biomarker for primary screening. However, multiple biomarker signatures (such as A/T/N) combined with ML algorithms (like XGBoost) greatly improve diagnostic accuracy for mild cognitive impairment. Notably, predictive performance is maximized with multimodal fusion, which integrates data from blood, neuroimaging, and genetics, achieving an area under the curve of up to 0.94. To mitigate the black-box nature of these models, explainable AI frameworks like SHapley Additive exPlanations (SHAP) are essential for establishing clinical interpretability. Ultimately, we propose a scalable “Step-Care” framework that transitions from single-biomarker community screening to precise multimodal fusion, optimizing clinical trial stratification and personalized workflows.
- 23 September 2026
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 18, 1937244
Open AccessBlood biomarkers and artificial intelligence: toward precision medicine in Alzheimer’s disease
The integration of blood-based biomarkers and artificial intelligence (AI) is revolutionizing the diagnostic landscape of Alzheimer’s disease (AD). In this paper, we synthesize recent advancements in the application of machine learning (ML) on blood biomarker analysis, evaluating their diagnostic efficacy and clinical translational potential. Current evidence identifies plasma p-tau217 as the best individual biomarker for primary screening. However, multiple biomarker signatures (such as A/T/N) combined with ML algorithms (like XGBoost) greatly improve diagnostic accuracy for mild cognitive impairment. Notably, predictive performance is maximized with multimodal fusion, which integrates data from blood, neuroimaging, and genetics, achieving an area under the curve of up to 0.94. To mitigate the black-box nature of these models, explainable AI frameworks like SHapley Additive exPlanations (SHAP) are essential for establishing clinical interpretability. Ultimately, we propose a scalable “Step-Care” framework that transitions from single-biomarker community screening to precise multimodal fusion, optimizing clinical trial stratification and personalized workflows.
- 18 June 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 112 (3) , 1182-1193
Deep white matter injury and cognitive decline in cerebral small vessel disease: Mediation by a unified atrophy network
Background: In cerebral small vessel disease (CSVD), the burden of white matter hyperintensities (WMH) does not fully account for cognitive impairment, suggesting the involvement of intermediary mechanisms. Objective: We investigated whether a gray matter atrophy network acts as the key mediator linking topologically specific (deep) WMH to multidomain cognitive dysfunction. Methods: In this retrospective study, 260 patients with CSVD (62 cognitively normal, 125 with mild impairment, 73 with dementia) were included. Cognitive status was assessed neuropsychologically. 3.0 T MRI identified an atrophy network. We then conducted pre-specified mediation analyses and a primary confirmatory analysis using structural equation modeling (SEM) to test whether this atrophy network mediated the effect of deep WMH on cognitive performance. Results: A 41-region atrophy network was identified , primarily involving the medial temporal lobe and thalamus, that was significantly associated with cognitive status. The final SEM demonstrated excellent fit, showing that higher deep WMH burden was associated with greater network atrophy ( β = 0.145, p < 0.05), which in turn was strongly associated with poorer executive function ( β = −0.64, p < 0.001) and memory ( β = −0.572, p < 0.001). The direct effect of WMH on cognition was not statistically significant in the model. Conclusions: Our findings suggest that in CSVD, a unified network of gray matter atrophy acts as a powerful statistical mediator in the effect of deep white matter injury on cognitive decline. This atrophy pattern may represent a more direct biomarker of the neurodegenerative process underlying cognitive impairment than WMH burden alone.
- 18 June 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 112 (3) , 1182-1193
Deep white matter injury and cognitive decline in cerebral small vessel disease: Mediation by a unified atrophy network
Background: In cerebral small vessel disease (CSVD), the burden of white matter hyperintensities (WMH) does not fully account for cognitive impairment, suggesting the involvement of intermediary mechanisms. Objective: We investigated whether a gray matter atrophy network acts as the key mediator linking topologically specific (deep) WMH to multidomain cognitive dysfunction. Methods: In this retrospective study, 260 patients with CSVD (62 cognitively normal, 125 with mild impairment, 73 with dementia) were included. Cognitive status was assessed neuropsychologically. 3.0 T MRI identified an atrophy network. We then conducted pre-specified mediation analyses and a primary confirmatory analysis using structural equation modeling (SEM) to test whether this atrophy network mediated the effect of deep WMH on cognitive performance. Results: A 41-region atrophy network was identified , primarily involving the medial temporal lobe and thalamus, that was significantly associated with cognitive status. The final SEM demonstrated excellent fit, showing that higher deep WMH burden was associated with greater network atrophy ( β = 0.145, p < 0.05), which in turn was strongly associated with poorer executive function ( β = −0.64, p < 0.001) and memory ( β = −0.572, p < 0.001). The direct effect of WMH on cognition was not statistically significant in the model. Conclusions: Our findings suggest that in CSVD, a unified network of gray matter atrophy acts as a powerful statistical mediator in the effect of deep white matter injury on cognitive decline. This atrophy pattern may represent a more direct biomarker of the neurodegenerative process underlying cognitive impairment than WMH burden alone.
- Open Access
- 5 June 2026
- Published by Elsevier in The Journal Of Prevention of Alzheimer's Disease
- Vol. 13 (7) , 100614
The growing burden of dementia in Asia: Comparative insights from Japan, China, and India
- 5 June 2026
- Published by Elsevier in The Journal Of Prevention of Alzheimer's Disease
- Vol. 13 (7) , 100614
Open AccessThe growing burden of dementia in Asia: Comparative insights from Japan, China, and India
- Open Access
- 1 January 2026
- Published by Elsevier in The Journal Of Prevention of Alzheimer's Disease
- Vol. 13 (3) , 100472
Association of plasma p-tau and p-tau/Aβ ratio with Alzheimer's pathology
- 1 January 2026
- Published by Elsevier in The Journal Of Prevention of Alzheimer's Disease
- Vol. 13 (3) , 100472
Open AccessAssociation of plasma p-tau and p-tau/Aβ ratio with Alzheimer's pathology
- Open Access
- 25 April 2023
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 8 (6) , 444-452
Photochemically induced thalamus infarction impairs cognition in a mouse model
Background Small subcortical infarcts account for up to 25% of ischaemic strokes. Thalamus is one of the subcortical structures that commonly manifest with lacunar infarcts on MRI of the brain. Studies have shown that thalamus infarction is associated with cognitive decline. However, due to the lack of proper animal models, little is known about the mechanism. We aimed to establish a focal thalamus infarction model, characterise the infarct lesion and assess functional effects. Methods Male C57BL/6J mice were anaesthetised, and Rose Bengal dye was injected through the tail vein. The right thalamus was illuminated with green laser light by stereotactic implantation of optic fibre. Characteristics of the infarct and lesion evolution were evaluated by histological analysis and 7T MRI at various times. The cognitive and neurological functions were assessed by behavioural tests. Retrograde tracing was performed to analyse neural connections. Results An ischaemic lesion with small vessel occlusion was observed in the thalamus. It became a small circumscribed infarct with reactive astrocytes accumulated in the infarct periphery on day 21. The mice with thalamic infarction demonstrated impaired learning and memory without significant neurological deficits. Retrogradely labelled neurons in the retrosplenial granular cortex were reduced. Conclusion This study established a mouse model of thalamic lacunar infarction that exhibits cognitive impairment. Neural connection dysfunctions may play a potential role in post-stroke cognitive impairment. This model helps to clarify the pathophysiology of post-stroke cognitive impairment and to develop potential therapies.
- 25 April 2023
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 8 (6) , 444-452
Open AccessPhotochemically induced thalamus infarction impairs cognition in a mouse model
Background Small subcortical infarcts account for up to 25% of ischaemic strokes. Thalamus is one of the subcortical structures that commonly manifest with lacunar infarcts on MRI of the brain. Studies have shown that thalamus infarction is associated with cognitive decline. However, due to the lack of proper animal models, little is known about the mechanism. We aimed to establish a focal thalamus infarction model, characterise the infarct lesion and assess functional effects. Methods Male C57BL/6J mice were anaesthetised, and Rose Bengal dye was injected through the tail vein. The right thalamus was illuminated with green laser light by stereotactic implantation of optic fibre. Characteristics of the infarct and lesion evolution were evaluated by histological analysis and 7T MRI at various times. The cognitive and neurological functions were assessed by behavioural tests. Retrograde tracing was performed to analyse neural connections. Results An ischaemic lesion with small vessel occlusion was observed in the thalamus. It became a small circumscribed infarct with reactive astrocytes accumulated in the infarct periphery on day 21. The mice with thalamic infarction demonstrated impaired learning and memory without significant neurological deficits. Retrogradely labelled neurons in the retrosplenial granular cortex were reduced. Conclusion This study established a mouse model of thalamic lacunar infarction that exhibits cognitive impairment. Neural connection dysfunctions may play a potential role in post-stroke cognitive impairment. This model helps to clarify the pathophysiology of post-stroke cognitive impairment and to develop potential therapies.
- Open Access
- 21 April 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (5) , 528
7T MRI for Intracranial Vessel Wall Lesions and Its Associated Neurological Disorders: A Systematic Review
Intracranial vessel wall lesions are involved in a variety of neurological diseases. The advanced technique 7T MRI provides greater efficacy in the diagnosis of the pathology changes in the vessel wall and helps to identify potential subtle lesions. The purpose of this literature review was to systematically describe and evaluate the existing literature focusing on the use of 7T MRI in the detection and characterization of intracranial vessel wall lesions and their associated neurological disorders, to highlight the current knowledge gaps, and to formulate a framework to guide future applications and investigations. We systematically reviewed the existing articles up to July 2021, seeking the studies that assessed intracranial vessel wall lesions and their associated neurological disorders using 7T MRI. The literature search provided 12 studies that met the inclusion criteria. The most common intracranial vessel wall lesions were changes related to intracranial atherosclerosis (n = 8) and aneurysms (n = 4), such as intracranial atherosclerosis burden and aneurysm wall enhancement. The associated neurological disorders included aneurysms, ischemic stroke or TIA, small vessel disease, cognitive decline, and extracranial atherosclerosis. No paper studied the use of 7T MRI for investigating vessel wall conditions such as moyamoya disease, small vessel disease, or neurological disorders related to central nervous vasculitis. In conclusion, the novel 7T MRI enables the identification of a wider spectrum of subtle changes and associations. Future research on cerebral vascular diseases other than intracranial atherosclerosis and aneurysms may also benefit from 7T MRI.
- 21 April 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (5) , 528
Open Access7T MRI for Intracranial Vessel Wall Lesions and Its Associated Neurological Disorders: A Systematic Review
Intracranial vessel wall lesions are involved in a variety of neurological diseases. The advanced technique 7T MRI provides greater efficacy in the diagnosis of the pathology changes in the vessel wall and helps to identify potential subtle lesions. The purpose of this literature review was to systematically describe and evaluate the existing literature focusing on the use of 7T MRI in the detection and characterization of intracranial vessel wall lesions and their associated neurological disorders, to highlight the current knowledge gaps, and to formulate a framework to guide future applications and investigations. We systematically reviewed the existing articles up to July 2021, seeking the studies that assessed intracranial vessel wall lesions and their associated neurological disorders using 7T MRI. The literature search provided 12 studies that met the inclusion criteria. The most common intracranial vessel wall lesions were changes related to intracranial atherosclerosis (n = 8) and aneurysms (n = 4), such as intracranial atherosclerosis burden and aneurysm wall enhancement. The associated neurological disorders included aneurysms, ischemic stroke or TIA, small vessel disease, cognitive decline, and extracranial atherosclerosis. No paper studied the use of 7T MRI for investigating vessel wall conditions such as moyamoya disease, small vessel disease, or neurological disorders related to central nervous vasculitis. In conclusion, the novel 7T MRI enables the identification of a wider spectrum of subtle changes and associations. Future research on cerebral vascular diseases other than intracranial atherosclerosis and aneurysms may also benefit from 7T MRI.